Pepdox
Studies
Peptides
Calculator
Once-weekly  semaglutide  for obesity  or overweight: A systematic review and meta-analysis. | Pepdox
Home
/
Search
/
PMID 34866313
Once-weekly semaglutide for obesity or overweight: A systematic review and meta-analysis.
Diabetes, obesity & metabolism
2022
PMID: 34866313
View on PubMed
DOI: 10.1111/dom.14612
Review
Meta-Analysis
Semaglutide
Authors
He, Ke; Guo, Qing; Zhang, Haijuan; Xi, Wang; Li, Jingxin; Jing, Zeng
Keywords
meta-analysis
obesity
overweight
randomized controlled trials
semaglutide